ParcelBioNext-generation mRNA medicines

ParcelBio is revolutionizing mRNA medicine with its STAmP technology. This nanoparticle-free platform delivers mRNA safely and specifically to diverse cell types, enabling fully customizable treatments.

mRNA Delivery

Targeted Drug Delivery

Nanoparticle-Free Technology

ParcelBio Alternatives

Sensible Biotechnologies

Engineering cells to unlock the next generation of mRNA medicines

Helix Nanotechnologies

Next-generation mRNA platform to solve cancer, COVID and climate.

Kernal Biologics

Kernal is creating mRNA 2.0 therapies that work in specific cells

Sixfold Bioscience

Delivering RNA therapies.

Cisterna Biologics

High quality mRNA for therapeutic application

Engage Bio

mRNA Immunotherapies to Eliminate Cancer

SynsoryBio

"If-then" conditional logic for protein drugs

GEn1E Lifesciences

AI platform accelerating therapies for rare & inflammatory diseases.

ParcelBio

ParcelBio is pioneering the next generation of RNA medicines. The company is dedicated to developing innovative treatments for a range of diseases.

Product Highlights

Targeted Delivery: Proprietary technology that precisely delivers medication to target cells.
High Efficacy: Achieves high success rates in treatment.
Enhanced Safety: Reduced side effects compared to traditional therapies.

Use Cases

Gene Therapy: Offering novel solutions for treating genetic diseases.
Cancer Therapy: Improving treatment effectiveness and reducing side effects.
Immunotherapy: Developing new medicines to strengthen the immune system.

Target Audience

ParcelBio targets pharmaceutical companies, research centers, and biotechnology companies seeking innovative solutions to treat diseases.